Rupa Padaki

Non-targeted characterization of attributes affecting antibody-FcγRIIIa V158 (CD16a) binding via online affinity chromatography-mass spectrometry

T. Dillon, P. Bondarenko, S. Kuhns, 2022, mAbs.

Immune Complex Formation Is Associated With Loss of Tolerance and an Antibody Response to Both Drug and Target

Troy E. Barger, H. Hsu, M. C. Teixeira dos Santos, 2021, Frontiers in Immunology.

Molecular and Functional Characterization of Cynomolgus Monkey IgG Subclasses

T. Arora, A. Morris, R. Armitage, 2011, The Journal of Immunology.

Differences in binding and effector functions between classes of TNF antagonists.

T. Arora, T. Kohno, A. Ellison, 2009, Cytokine.

Mouse Monoclonal Antibodies to Transient Receptor Potential Ankyrin 1 Act as Antagonists of Multiple Modes of Channel Activation

N. Gavva, Rupa Padaki, Cherylene A Plewa, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Development of in silico models to predict viscosity and mouse clearance using a comprehensive analytical data set collected on 83 scaffold-consistent monoclonal antibodies

Iain D G Campuzano, S. Ghimire-Rijal, Rupa Padaki, 2023, mAbs.

Utility of physiologically based pharmacokinetic modeling to predict inter-antibody variability in monoclonal antibody pharmacokinetics in mice

Rupa Padaki, Veena A. Thomas, Alex W. Jacobitz, 2023, mAbs.